Biovica International, headquartered in Uppsala, uses an FDA 510(k)-cleared assay.
3 reports, 2 independent
Updated Jul 7
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biovica International, headquartered in Uppsala, uses an FDA 510(k)-cleared assay.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A product was launched in the U.S. market following FDA involvement.
- FDA approved a new potency assay for product lots from Mesoblast.
- FDA has not assured peptide identity or purity regarding a matter involving Mount Sinai.
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.